Display options
Cite
Rebbeck TR, Devesa SS, Chang BL, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013;2013:560857doi: 10.1155/2013/560857.
Rebbeck, T. R., Devesa, S. S., Chang, B. L., Bunker, C. H., Cheng, I., Cooney, K., Eeles, R., Fernandez, P., Giri, V. N., Gueye, S. M., Haiman, C. A., Henderson, B. E., Heyns, C. F., Hu, J. J., Ingles, S. A., Isaacs, W., Jalloh, M., John, E. M., Kibel, A. S., Kidd, L. R., Layne, P., Leach, R. J., Neslund-Dudas, C., Okobia, M. N., Ostrander, E. A., Park, J. Y., Patrick, A. L., Phelan, C. M., Ragin, C., Roberts, R. A., Rybicki, B. A., Stanford, J. L., Strom, S., Thompson, I. M., Witte, J., Xu, J., Yeboah, E., Hsing, A. W., & Zeigler-Johnson, C. M. (2013). Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate cancer, 2013560857. https://doi.org/10.1155/2013/560857
Rebbeck, Timothy R, et al. "Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent." Prostate cancer vol. 2013 (2013): 560857. doi: https://doi.org/10.1155/2013/560857
Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, Isaacs W, Jalloh M, John EM, Kibel AS, Kidd LR, Layne P, Leach RJ, Neslund-Dudas C, Okobia MN, Ostrander EA, Park JY, Patrick AL, Phelan CM, Ragin C, Roberts RA, Rybicki BA, Stanford JL, Strom S, Thompson IM, Witte J, Xu J, Yeboah E, Hsing AW, Zeigler-Johnson CM. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013;2013:560857. doi: 10.1155/2013/560857. Epub 2013 Feb 13. PMID: 23476788; PMCID: PMC3583061.
Copy Download .nbib Format: NLM
Share it on

Prostate Cancer. 2013;2013:560857. doi: 10.1155/2013/560857. Epub 2013 Feb 13.

Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent.

Prostate cancer

Timothy R Rebbeck, Susan S Devesa, Bao-Li Chang, Clareann H Bunker, Iona Cheng, Kathleen Cooney, Rosalind Eeles, Pedro Fernandez, Veda N Giri, Serigne M Gueye, Christopher A Haiman, Brian E Henderson, Chris F Heyns, Jennifer J Hu, Sue Ann Ingles, William Isaacs, Mohamed Jalloh, Esther M John, Adam S Kibel, Lacreis R Kidd, Penelope Layne, Robin J Leach, Christine Neslund-Dudas, Michael N Okobia, Elaine A Ostrander, Jong Y Park, Alan L Patrick, Catherine M Phelan, Camille Ragin, Robin A Roberts, Benjamin A Rybicki, Janet L Stanford, Sara Strom, Ian M Thompson, John Witte, Jianfeng Xu, Edward Yeboah, Ann W Hsing, Charnita M Zeigler-Johnson

Affiliations

  1. Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 217 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA ; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

PMID: 23476788 PMCID: PMC3583061 DOI: 10.1155/2013/560857

Abstract

Prostate cancer (CaP) is the leading cancer among men of African descent in the USA, Caribbean, and Sub-Saharan Africa (SSA). The estimated number of CaP deaths in SSA during 2008 was more than five times that among African Americans and is expected to double in Africa by 2030. We summarize publicly available CaP data and collected data from the men of African descent and Carcinoma of the Prostate (MADCaP) Consortium and the African Caribbean Cancer Consortium (AC3) to evaluate CaP incidence and mortality in men of African descent worldwide. CaP incidence and mortality are highest in men of African descent in the USA and the Caribbean. Tumor stage and grade were highest in SSA. We report a higher proportion of T1 stage prostate tumors in countries with greater percent gross domestic product spent on health care and physicians per 100,000 persons. We also observed that regions with a higher proportion of advanced tumors reported lower mortality rates. This finding suggests that CaP is underdiagnosed and/or underreported in SSA men. Nonetheless, CaP incidence and mortality represent a significant public health problem in men of African descent around the world.

References

  1. Nat Genet. 2011 Jun;43(6):570-3 - PubMed
  2. Cancer Biol Ther. 2010 Jun 15;9(12):994-9 - PubMed
  3. Infect Agent Cancer. 2009 Feb 10;4 Suppl 1:S2 - PubMed
  4. Prostate. 2010 Jul 1;70(10):1102-9 - PubMed
  5. J Urol. 1997 Apr;157(4):1340-3 - PubMed
  6. Cancer Res. 2005 Jun 15;65(12):5470-9 - PubMed
  7. Int J Cancer. 2010 Dec 15;127(12):2893-917 - PubMed
  8. Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):23-32 - PubMed
  9. Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):881-6 - PubMed
  10. Am J Epidemiol. 2008 Aug 1;168(3):250-60 - PubMed
  11. Cancer Detect Prev. 2006;30(5):412-22 - PubMed
  12. Urology. 2007 Aug;70(2):374-9 - PubMed
  13. BJU Int. 2002 Mar;89(4):390-5 - PubMed
  14. J Urol. 2007 Nov;178(5):1920-4; discussion 1924 - PubMed
  15. J Natl Cancer Inst. 1998 Aug 19;90(16):1225-9 - PubMed
  16. Int J Urol. 2003 Jun;10(6):315-22 - PubMed
  17. PLoS Genet. 2011 May;7(5):e1001387 - PubMed
  18. Carcinogenesis. 2008 Dec;29(12):2347-50 - PubMed
  19. Prostate. 2008 Apr 1;68(5):563-70 - PubMed
  20. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):726-9 - PubMed
  21. Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2145-9 - PubMed
  22. Cancer Causes Control. 2001 Feb;12(2):147-52 - PubMed
  23. Lancet. 2012 Apr 14;379(9824):1390-1 - PubMed
  24. BMC Cancer. 2010 Jun 28;10:334 - PubMed
  25. Nig Q J Hosp Med. 2009 Jul-Sep;19(3):145-7 - PubMed
  26. Can J Urol. 2008 Feb;15(1):3883-5 - PubMed
  27. Mol Nutr Food Res. 2009 Feb;53(2):171-84 - PubMed
  28. Urology. 2001 Jan;57(1):91-6 - PubMed
  29. Cancer Invest. 2007 Sep;25(6):476-83 - PubMed
  30. J Clin Epidemiol. 2001 Feb;54(2):142-8 - PubMed
  31. Urology. 2003 May;61(5):987-92 - PubMed
  32. Am J Epidemiol. 2000 Feb 15;151(4):346-57 - PubMed
  33. Am J Epidemiol. 2006 Nov 15;164(10):984-9 - PubMed
  34. Prostate. 1980;1(2):185-205 - PubMed
  35. BJU Int. 2009 Jun;103(11):1482-6 - PubMed
  36. Urology. 2000 Aug 1;56(2):255-60 - PubMed
  37. Prostate Cancer Prostatic Dis. 2012 Jun;15(2):170-6 - PubMed
  38. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1869-80 - PubMed
  39. Carcinogenesis. 2009 Aug;30(8):1372-9 - PubMed
  40. Afr J Med Med Sci. 2000 Jun;29(2):97-100 - PubMed
  41. J Natl Cancer Inst. 2002 Jul 3;94(13):981-90 - PubMed

Publication Types

Grant support